Alzheimer’s drug plus clot buster caused brain hemorrhage death: report
By
Alicia Lasek
Jan 06, 2023
A clot-busting drug administered during a stroke helped lead to the death of a patient taking the experimental Alzheimer’s drug lecanemab, a peer-reviewed autopsy analysis has revealed.
Alzheimer’s drug lecanemab has ‘moderate’ effect on cognitive decline, new trial data show
By
Alicia Lasek
Dec 01, 2022
The experimental Alzheimer’s drug slowed decline in memory and thinking by 27% when compared with placebo, although 20% of patients reported adverse events.
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.
Remdesivir cuts risk of severe COVID-19 by 87 percent in non-hospitalized patients
By
Alicia Lasek
Jan 21, 2022
The results suggest that remdesivir (brand name Veklury) could be used to treat outpatients early in the disease course, researchers say. The drug currently is authorized for use only in hospitalized COVID-19...
Oral Inosine does not slow progression of early Parkinson disease
Sep 16, 2021
No significant difference seen in rate of clinical disease progression or in secondary efficacy outcomes versus placebo
Unfavorable article against hip device firm holds up in court
Mar 20, 2013
The maker of a device used to protect fragile hip joints in nursing home residents failed to raise sufficient evidence to justify a trade disparagement claim against the author of an unfavorable article,...
Massive trial to determine effects of lower blood pressure on dementia
Mar 22, 2010
The largest-ever clinical trial to determine the effect of lower blood pressure on dementia is preparing to enroll participants, according to recent reports.